Galle P et al. Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: Outcomes by liver disease aetiology front wo randomised, placebo-controlled phase 3 studies (REACH-2 and REACH). (Abstract GS-09)
Trombose bij kinderen en adolescenten die zijn opgenomen met COVID-19 of MIS-C
sep 2021 | Benigne hematologie, Virale infecties